<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1715</article-id><article-id pub-id-type="doi">10.32687/1561-5936-2024-28-2-104-108</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>The activities of public organizations to reduce inequality in the availability of medicines to the population. Part 2. Public organizations and their role in drug provision issues</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Vrubel</surname><given-names>Maria E.</given-names></name><bio></bio><email>mariavrubel@gmail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">N. A. Semashko National Research Institute of Public Health, Moscow, Russian Federation</aff><pub-date date-type="epub" iso-8601-date="2024-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2024</year></pub-date><issue>2</issue><fpage>104</fpage><lpage>108</lpage><history><pub-date date-type="received" iso-8601-date="2025-10-15"><day>15</day><month>10</month><year>2025</year></pub-date></history><permissions><copyright-statement>Copyright © 2024,</copyright-statement><copyright-year>2024</copyright-year></permissions><abstract>Between 70 and 95% of medical visits end with prescribing medicines, while almost 2 billion people worldwide do not have access to essential medicines. The presented work is aimed at studying the problems of drug deficiency and the task of reducing it within the framework of the Sustainable Development Goals, as well as the research activities of public organizations on reducing socio-economic inequality and access of the population and representatives of certain groups to medicines.</abstract><kwd-group xml:lang="en"><kwd>drug provision</kwd><kwd>accessibility</kwd><kwd>inequality</kwd><kwd>public organizations</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>лекарственное обеспечение</kwd><kwd>доступность</kwd><kwd>неравенство</kwd><kwd>общественные организации</kwd></kwd-group></article-meta></front><body></body><back/></article>
